Revolution Medicines’ potential breakthrough pancreatic cancer drug succeeds in late-stage trialApril 13, 2026
Share Facebook Twitter LinkedIn Pinterest Email Sebastian Siemiatkowski, Klarna CEO, discussed the U.S. consumer’s response to buy now, pay later options versus store credit cards.